Keyphrases
2-dose
20%
Adolescent Girls
100%
Adult Women
20%
Congenital Infection
20%
Cytomegalovirus
100%
Cytomegalovirus Antigen
20%
Cytomegalovirus Infection
40%
Geometric Mean Titer
20%
Glycoprotein B
100%
Immunogenic
20%
MF59
20%
Placebo
80%
Randomized Clinical Trial
100%
Seroconversion
20%
Systemic Side Effects
20%
Vaccine Development
20%
Vaccine Effectiveness
40%
Vaccine Response
20%
Pharmacology, Toxicology and Pharmaceutical Science
Administered Dose
20%
Adverse Event
20%
Congenital Infection
20%
Cytomegalovirus
100%
Cytomegalovirus Infection
40%
Cytomegalovirus Vaccine
20%
Glycoprotein B
100%
MF59
20%
Placebo
80%
Randomized Clinical Trial
100%
Vaccine Development
20%
Vaccine Efficacy
40%
Biochemistry, Genetics and Molecular Biology
Cytomegalovirus
100%
Glycoprotein
100%
Randomized Clinical Trial
100%
Seroconversion
12%
Titer
12%